Loading COMP…
Loading financial statements…
Import this data to Google Sheets with:
=jivedata("COMP","financials")Full statements spill as a table. For one cell: =jivedata("COMP","Revenue") or =jivedata("COMP","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.
COMP • CIK 0001563190
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Revenues | $4,885,000 | $5,629,100 | $6,961,600 | $10,555,800 |
| Operating Income (Loss) | $-314,900 | $-154,800 | $-63,400 | $-276,100 |
| Investment Income, Nonoperating | $8,500 | $6,800 | $5,500 | $11,400 |
| InterestExpenseNonoperating | — | $6,400 | $9,000 | $9,000 |
| Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest | $-317,200 | $-154,400 | $-66,900 | $-346,700 |
| Income Tax Expense (Benefit) | $-400 | $-500 | $-1,100 | $-394,000 |
| Income (Loss) from Equity Method Investments | $-3,300 | $-600 | $7,100 | $19,600 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-320,100 | $-154,500 | $-58,700 | $66,900 |
| Net Income (Loss) Attributable to Noncontrolling Interest | $1,200 | $-100 | $-200 | $100 |
| Net Income (Loss) Attributable to Parent | $-321,300 | $-154,400 | $-58,500 | $66,800 |
| Weighted Average Number of Shares Outstanding, Basic | 466,522,935 | 501,514,681 | 562,153,375 | 753,171,396 |
| Sales Commissions and Fees | $4,007,000 | $4,634,600 | $5,679,700 | $8,149,900 |
| Other Selling and Marketing Expense | $435,400 | $368,700 | $377,900 | $394,800 |
| Other Cost and Expense, Operating | $326,900 | $334,500 | $429,400 | $1,050,400 |
| Research and Development Expense | $184,500 | $188,800 | $245,800 | $245,800 |
| General and Administrative Expense | $125,700 | $165,200 | $144,300 | $257,500 |
| Restructuring Charges | $30,400 | $9,700 | $17,100 | $13,200 |
| Depreciation, Depletion and Amortization, Nonproduction | $90,000 | $82,400 | $112,700 | $370,500 |
| Operating Expenses | $5,199,900 | $5,783,900 | $7,025,000 | $10,831,900 |
| Restructuring and Related Cost, Incurred Cost | $35,700 | $11,700 | $17,900 | $14,000 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Property, Plant and Equipment, Net | $151,700 | $125,500 | $113,800 | $113,800 |
| Operating Lease, Right-of-Use Asset | $408,500 | $389,700 | $381,100 | $690,000 |
| Intangible Assets, Net (Excluding Goodwill) | $77,600 | $73,800 | $193,300 | $2,972,000 |
| Goodwill | $209,800 | $233,600 | $479,200 | $2,558,000 |
| Other Assets, Noncurrent | $30,700 | $25,400 | $54,900 | $505,000 |
| Assets | $1,160,300 | $1,178,000 | $1,539,500 | $8,332,000 |
| Operating Lease, Liability, Noncurrent | $410,200 | $380,500 | $354,200 | $594,000 |
| Other Liabilities, Noncurrent | $25,600 | $31,900 | $30,700 | $146,000 |
| Liabilities | $728,300 | $765,600 | $752,200 | $5,345,000 |
| Cash and Cash Equivalents, at Carrying Value | $166,900 | $223,800 | $199,000 | $694,000 |
| Accounts Receivable, after Allowance for Credit Loss, Current | $36,600 | $48,600 | $57,000 | $239,000 |
| Financing Receivable, after Allowance for Credit Loss, Current | $24,000 | $24,400 | $25,000 | $25,000 |
| Other Assets, Current | $54,500 | $33,200 | $36,200 | $238,000 |
| Assets, Current | $282,000 | $330,000 | $317,200 | $1,385,000 |
| Accounts Payable, Current | $18,400 | $13,000 | $12,500 | $101,000 |
| Accrued Sales Commission, Current | $59,600 | $82,800 | $94,800 | $246,000 |
| Other Accrued Liabilities, Current | $90,800 | $140,300 | $138,000 | $583,000 |
| Operating Lease, Liability, Current | $98,900 | $93,500 | $99,300 | $178,000 |
| Liabilities, Current | $292,500 | $353,200 | $367,300 | $1,303,000 |
| Common Stock, Value, Issued | $0 | $0 | $0 | $0 |
| Additional Paid in Capital, Common Stock | $2,946,500 | $3,081,600 | $3,512,700 | $5,597,000 |
| Retained Earnings (Accumulated Deficit) | $-2,517,800 | $-2,672,200 | $-2,730,700 | $-2,617,000 |
| Stockholders' Equity Attributable to Parent | $428,700 | $409,400 | $782,000 | $2,979,000 |
| Stockholders' Equity Attributable to Noncontrolling Interest | $3,300 | $3,000 | $5,300 | $8,000 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | $432,000 | $412,400 | $787,300 | $2,987,000 |
| Accounts Receivable, Allowance for Credit Loss, Current | $8,600 | $4,400 | $3,500 | $16,000 |
| Financing Receivable, Allowance for Credit Loss, Current | $13,200 | $10,400 | $9,700 | $9,700 |
| Common Stock, Shares Authorized | 13,850,000,000 | 13,850,000,000 | 13,850,000,000 | 13,850,000,000 |
| Common Stock, Shares, Issued | 484,893,266 | 513,143,108 | 563,479,423 | 753,281,560 |
| (in thousands, except per share data) | FY 2023 | FY 2024 | FY 2025 | TTM |
|---|---|---|---|---|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $-195,000 | $56,900 | $-24,800 | $357,000 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $166,900 | $223,800 | $199,000 | $556,000 |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $-320,100 | $-154,500 | $-58,700 | $66,900 |
| Net Cash Provided by (Used in) Operating Activities | $-25,900 | $121,500 | $216,700 | $154,800 |
| Payments to Acquire Interest in Subsidiaries and Affiliates | $1,200 | $2,000 | $3,900 | $2,400 |
| Payments to Acquire Property, Plant, and Equipment | $11,200 | $15,700 | $13,400 | $27,000 |
| Payments to Acquire Businesses, Net of Cash Acquired | $-700 | $18,900 | $174,000 | $347,000 |
| Net Cash Provided by (Used in) Investing Activities | $-11,700 | $-36,600 | $-191,300 | $-375,400 |
| Proceeds from Stock Options Exercised | $4,500 | $9,500 | $17,800 | $22,700 |
| Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | $2,500 | $2,200 | $2,900 | $3,600 |
| Payment, Tax Withholding, Share-based Payment Arrangement | $23,500 | $35,000 | $61,100 | $111,500 |
| Payments of Debt Issuance Costs | — | — | $4,100 | $4,100 |
| Payment for Contingent Consideration Liability, Financing Activities | $14,600 | $3,400 | $7,400 | $7,400 |
| Proceeds from (Payments for) Other Financing Activities | $-1,500 | $-100 | $2,600 | $-13,400 |
| Net Cash Provided by (Used in) Financing Activities | $-157,400 | $-28,000 | $-50,200 | $738,300 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $9,000 | $3,400 | $5,600 | $83,900 |
| Stock Issued | $17,900 | $26,600 | $264,300 | $1,998,600 |
| Depreciation, Depletion and Amortization | $90,000 | $82,400 | $112,700 | $370,500 |
| Share-based Payment Arrangement, Noncash Expense | $158,200 | $127,500 | $202,700 | $266,100 |
| Income (Loss) from Equity Method Investments | $-3,300 | $-600 | $7,100 | $19,600 |
| Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | $2,600 | $6,000 | $-200 | $3,300 |
| Amortization of Debt Issuance Costs | $700 | $700 | $1,000 | $1,000 |
| Increase (Decrease) in Accounts Receivable | $3,500 | $8,000 | $-7,100 | $27,800 |
| Increase (Decrease) in Finance Receivables | $-18,000 | $800 | $1,000 | $1,000 |
| Increase (Decrease) in Other Current Assets | $-21,400 | $-21,300 | $-1,700 | $-1,700 |
| Increase (Decrease) in Other Noncurrent Assets | $-9,100 | $-7,000 | $6,800 | $6,800 |
| Increase (Decrease) in Accounts Payable, Trade | $-9,800 | $-6,300 | $-2,800 | $-2,500 |
| Increase (Decrease) in Other Accrued Liabilities | $-10,600 | $42,000 | $-24,600 | $-106,100 |